Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* ("Fosun Pharma"; stock code: 600196. SH, 02196. HK) is a global innovation-driven pharmaceutical and healthcare industry group. Fosun Pharma directly operates businesses including pharmaceuticals, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business. Fosun Pharma is patient-centered and clinical needs-oriented. The company continuously enriches its innovative product pipeline through independent research and development, cooperative development, license-in, and in-depth incubation. Fosun Pharma improves the research and clinical development capabilities of FIC (First-in-class) and BIC (Best-in-class) new drugs as well as accelerates the R&D and launch of innovative technologies and products. Fosun Pharma’s innovative products mainly covered core therapeutic areas such as tumors (solid tumors and hematologic tumors), immunology, central nervous system, and chronic diseases (liver disease/metabolism/kidney disease). Guided by the 4IN strategy (Innovation, Internationalization, Intelligentization, and Integration), Fosun Pharma will uphold the development model of “Innovation Transformation, Integrated Operation and Steady Growth", with the mission of creating shareholder values through strengthening its independent R&D and external cooperation and enriching its product pipelines, as well as promoting the global networks and enhancing operational efficiency. Fosun Pharma will actively promote the digital and physical business layout in the pharmaceutical and healthcare industry and is committed to becoming a first-class enterprise in the global pharmaceutical and healthcare markets.
View Top Employees from Fosun PharmaWebsite | http://www.fosunpharma.com/ |
Ticker | HKG:2196 |
Revenue | $22.02 billion |
Employees | 4,535 (367 on RocketReach) |
Founded | 1994 |
Address | Building a No. 1289 Yishan Rd, Shanghai, Shanghai 200233, CN |
Phone | +86 21 3398 7000 |
Fax | +86 21 3398 7020 |
Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Biotechnology, Drug Delivery, Healthcare, Science and Engineering, Health Care, Medical, Pharmaceutical |
Web Rank | 956244 |
Keywords | Pharmaceutical Healthcare, Pharmaceutical Research, Medical Devices, Healthcare Service, Drug Development And Manufacturing, Clinical Trials, Innovative Medicine, Patient-Centric Healthcare, Biotechnology, Healthcare Technologies |
Competitors | Chiesi Group, Max Healthcare, Modimundi Pharma, 华润水泥有限公司, 海南亚特兰蒂斯商旅发展有限公司 |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Fosun Pharma employee's phone or email?
The Fosun Pharma annual revenue was $22.02 billion in 2024.
Xing Wang is the Executive President of Fosun Pharma.
367 people are employed at Fosun Pharma.
Fosun Pharma is based in Shanghai, Shanghai.
The NAICS codes for Fosun Pharma are [3254, 325, 32, 32541].
The SIC codes for Fosun Pharma are [28, 283].